ESR1 and neoplasm: In the TCGA cohort, CILP displayed a differential expression pattern based on different clinical factors, including age, clinical stage, tumor size, lymph node status, metastasis, estrogen receptor (ER) status, and progesterone receptor (PR) status (Figure 2A).